Aquestive Therapeutics
AQST
AQST
51 hedge funds and large institutions have $40.7M invested in Aquestive Therapeutics in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 16 increasing their positions, 19 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
2.75% less ownership
Funds ownership: 40.24% → 37.49% (-2.7%)
16% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 19
35% less capital invested
Capital invested by funds: $62.9M → $40.7M (-$22.2M)
Holders
51
Holding in Top 10
2
Calls
$420K
Puts
$268K
Top Buyers
| 1 | +$1.21M | |
| 2 | +$250K | |
| 3 | +$208K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$118K |
| 5 |
BlackRock
New York
|
+$82.2K |
Top Sellers
| 1 | -$1.2M | |
| 2 | -$347K | |
| 3 | -$341K | |
| 4 |
IA
IndexIQ Advisors
New York
|
-$316K |
| 5 |
Morgan Stanley
New York
|
-$290K |